Related Experiment Video
Updated: Jun 7, 2026
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Endothelial dysfunction: potential clinical implications.
D Tousoulis1, M Koutsogiannis, N Papageorgiou
1Hippokration Hospital, Athens University Medical School, Greece. drtousoulis@hotmail.com
Minerva Medica
|October 30, 2010
Summary
Vascular endothelium dysfunction is linked to cardiovascular disease. While many agents aim to improve endothelial function by boosting nitric oxide, their clinical benefits remain uncertain.
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Pharmacology
Background:
- The vascular endothelium regulates anti-atherogenic effects.
- Endothelial damage and dysfunction are central to atherosclerosis development.
- Impaired endothelial function (EF) is a hallmark of cardiovascular disease.
Purpose of the Study:
- To review agents modulating endothelial function (EF).
- To assess strategies enhancing nitric oxide bioavailability for endothelial dysfunction.
Main Methods:
- Literature review of pharmaceutical agents.
- Analysis of studies on endothelial function modulators.
- Evaluation of clinical evidence for EF improvement.
Main Results:
- Multiple agents, including statins, ACE inhibitors, L-arginine, and folate, are investigated for EF.
- These agents target nitric oxide bioavailability.
- Clinical efficacy of these strategies is not definitively established.
Conclusions:
- Endothelial dysfunction is a key factor in cardiovascular disease.
- Various pharmaceutical interventions aim to improve EF.
- Further clinical validation is needed to confirm the benefits of current strategies for endothelial dysfunction.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...